Cargando…

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and understudied consequence of taxane chemotherapy for breast cancer treatment. CIPN symptoms include numbness combined with tingling sensations, persistent shooting, stabbing, or burning pain even in the absence of painful s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teran-Wodzinski, Patricia, Haladay, Douglas, Vu, Tuan, Ji, Ming, Coury, Jillian, Adams, Alana, Schwab, Lauren, Visovsky, Constance
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044705/ https://www.ncbi.nlm.nih.gov/pubmed/35477489 http://dx.doi.org/10.1186/s13063-022-06294-w

Ejemplares similares

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013)

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN
por: Holloway, Michael P, et al.
Publicado: (2016)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Prevention and Treatment for Chemotherapy-Induced Peripheral  Neuropathy: Therapies Based on CIPN Mechanisms
por: Hu, Lang-Yue, et al.
Publicado: (2019)

Challenges in the Conduct of Research: Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2013)

A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN)
por: Gadgil, Suvarna, et al.
Publicado: (2019)

Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin
por: Maihöfner, Christian, et al.
Publicado: (2021)

Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment
por: Zanville, Noah R., et al.
Publicado: (2016)

Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)()()
por: Karlsson, Jan Olof G., et al.
Publicado: (2017)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats
por: Mansooralavi, Niloufar, et al.
Publicado: (2023)

Effects of transcutaneous electrical nerve stimulation on chemotherapy-induced peripheral neuropathy symptoms (CIPN): a preliminary case-control study
por: Tonezzer, Tania, et al.
Publicado: (2017)

Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy
por: Trompetter, Hester.R., et al.
Publicado: (2021)

Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis
por: Spera, Maria C., et al.
Publicado: (2022)

Peripheral neuropathy in Parkinson’s disease: prevalence and functional impact on gait and balance
por: Corrà, Marta Francisca, et al.
Publicado: (2022)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
por: Sansone, Pasquale, et al.
Publicado: (2022)

Nurse Self-Evaluation of Assessment of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
por: Visovsky, Constance, et al.
Publicado: (2012)

Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process
por: Klafke, Nadja, et al.
Publicado: (2023)

Development of an In Vitro Assessment Method for Chemotherapy-Induced Peripheral Neuropathy (CIPN) by Integrating a Microphysiological System (MPS) with Morphological Deep Learning of Soma and Axonal Images
por: Matsuda, Kazuki, et al.
Publicado: (2023)

Dual-Tasking Effects on Gait and Turning Performance of Stroke Survivors with Diabetic Peripheral Neuropathy
por: Tajuddin, Kamaruzaman, et al.
Publicado: (2021)

Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
por: Myftiu, Blerim, et al.
Publicado: (2022)

The Evaluation of Gait and Balance for Patients with Early Diabetic Peripheral Neuropathy: A Cross-Sectional Study
por: Jiang, Xiaoyan, et al.
Publicado: (2022)

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study
por: Parsons, Susan K., et al.
Publicado: (2023)

p38/TF/HIF-α Signaling Pathway Participates in the Progression of CIPN in Mice
por: Yang, Yang, et al.
Publicado: (2019)

Treatment Considerations for the Management of Patients With Hormone Receptor–Positive Metastatic Breast Cancer
por: Visovsky, Constance
Publicado: (2014)

Calcium and Magnesium for Oxaliplatin-Induced Neurotoxicity: Issues in Study Design, Measurement, and Analysis
por: Visovsky, Constance
Publicado: (2015)

Writing a Successful Grant: Tips and Tools
por: Visovsky, Constance
Publicado: (2015)

Effects of ankle biofeedback training on strength, balance, and gait in patients with stroke
por: Kim, Sung-jin, et al.
Publicado: (2016)

Force-Control vs. Strength Training: The Effect on Gait Variability in Stroke Survivors
por: Patel, Prakruti, et al.
Publicado: (2021)

The SMARTIE Program: A Novel Initiative to Evaluate the Impact of AP Continuing Education on Clinical Practice
por: Kurtin, Sandra E., et al.
Publicado: (2017)

History of falls, gait, balance, and fall risks in older cancer survivors living in the community
por: Huang, Min H, et al.
Publicado: (2015)

Diabetic Gait Is Not Just Slow Gait: Gait Compensations in Diabetic Neuropathy
por: Henderson, Adrienne D., et al.
Publicado: (2019)

GAIT UNSTEADINESS AS AN INDICATOR OF COGNITIVE STATUS IN INDIVIDUALS WITH PERIPHERAL NEUROPATHY
por: Kang, Gu Eon, et al.
Publicado: (2019)

Balance, gait, functionality and strength: comparison between elderly fallers and non-fallers
por: Cebolla, Elaine C., et al.
Publicado: (2015)

The effect of balance and gait training on specific balance abilities of survivors with stroke: a systematic review and network meta-analysis
por: Zhang, Meng, et al.
Publicado: (2023)

Gait and balance performance of stroke survivors in South-Western Nigeria - A cross-sectional study
por: Obembe, Adebimpe Olayinka, et al.
Publicado: (2014)

Reliability and Validity of the EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale) among Thai Women with Breast Cancer Undergoing Taxane-Based Chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kk37ql8rq10efj2vt90u7naq6c